ReviewBioMed research international2014
The evolution of legislation in the field of Medically Assisted Reproduction and embryo stem cell research in European union members.
Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 51 citations in OpenAlex.
- Ethical analysis of the European normative framework on fertility preservation.BMC medical ethics · 2026Article
- Ethical constraints and dilemmas in the provision of in-vitro fertilization treatment in Ghana: from the perspectives of experts.BMC medical ethics · 2024Article
- COVID-19 and Female Fertility: An Observational Prospective Multicenter Cohort Study: Upholding Reproductive Rights in Emergency Circumstances.Diagnostics (Basel, Switzerland) · 2024Article
- Reproductive surrogacy in Ireland - an ethical and legal context.Irish journal of medical science · 2021Review
- Diagnosis and Treatment of Male Infertility-Related Fertilization Failure.Journal of clinical medicine · 2020Review
- Use ofUpsala journal of medical sciences · 2020Review
- Combined use of medically-assisted reproductive techniques: a new bioethical issue.Acta bio-medica : Atenei Parmensis · 2019Review
- CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.Journal of molecular biology · 2019Review
- Intrafamilial oocyte donation in classic galactosemia: ethical and societal aspects.Journal of inherited metabolic disease · 2018Article
- 3D Bioprinting Technology: Scientific Aspects and Ethical Issues.Science and engineering ethics · 2018Review
- Changing direction: the struggle of regulating assisted reproductive technology in Austria.Reproductive biomedicine & society online · 2016Article
- Enduring politics: the culture of obstacles in legislating for assisted reproduction technologies in Ireland.Reproductive biomedicine & society online · 2016Article
- Creating human germ cells for unmet reproductive needs.Nature biotechnology · 2016Article
- SIAMS survey on sexological screening during the assisted reproductive technologies in Italy.Journal of endocrinological investigation · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medically Assisted Reproduction (MAR), involving in vitro fertilisation (IVF), and research on embryos have created expectation to many people affected by infertility; at the same time it has generated a surplus of laws and ethical and social debates. Undoubtedly, MAR represents a rather new medical field and constant developments in medicine and new opportunities continue to defy the attempt to respond to those questions. In this paper, the authors reviewed the current legislation in the 28 EU member states trying to evaluate the different legislation paths adopted over the last 15 years and highlighting those EU countries with no specific legislation in place and MAR is covered by a general health Law and those countries in which there are no laws in this field but only "guidelines." The second aim of this work has been to compare MAR legislation and embryo research in EU countries, which derive from different origins ranging from an extremely prohibitive approach versus a liberal one, going through a cautious regulatory approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.